reglab/housing_qa huggingface dataset:
WA Rev Code § 69.43.140 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.43 - Precursor Drugs.|69.43.140 - Civil penalty—Pharmacy quality assurance commission waiver.

RCW 69.43.140 Civil penalty—Pharmacy quality assurance commission waiver.(1) In addition to the other penalties provided for in this chapter or in chapter 18.64 RCW, the pharmacy quality assurance commission may impose a civil penalty, not to exceed ten thousand dollars for each violation, on any licensee or registrant who has failed to comply with this chapter or the rules adopted under this chapter. In the case of a continuing violation, every day the violation continues shall be considered a separate violation.(2) The pharmacy quality assurance commission may waive the suspension or revocation of a license or registration issued under chapter 18.64 RCW, or waive any civil penalty under this chapter, if the licensee or registrant establishes that he or she acted in good faith to prevent violations of this chapter, and the violation occurred despite the licensee's or registrant's exercise of due diligence. In making such a determination, the pharmacy quality assurance commission may consider evidence that an employer trained employees on how to sell, transfer, or otherwise furnish substances specified in RCW 69.43.010(1) in accordance with applicable laws.[ 2013 c 19 § 78; 2001 c 96 § 12.]NOTES:Intent—Severability—2001 c 96: See notes following RCW 69.43.010.
WA Rev Code § 69.43.150 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.43 - Precursor Drugs.|69.43.150 - Application of chapter to local government.

RCW 69.43.150 Application of chapter to local government.This chapter is applicable and uniform throughout this state and in all counties, cities, code cities, and towns therein. A county, city, code city, or town may not adopt or enforce any ordinance, pertaining to this chapter, which prohibits conduct that is not prohibited under this chapter, or defining violations or penalties different from those provided under this chapter. However, this section does not preclude a county, city, code city, or town from revoking, canceling, suspending, or otherwise limiting a business or professional license it has issued for conduct that violates any provision of this chapter.[ 2001 c 96 § 13.]NOTES:Intent—Severability—2001 c 96: See notes following RCW 69.43.010.
WA Rev Code § 69.43.160 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.43 - Precursor Drugs.|69.43.160 - Ephedrine, pseudoephedrine, phenylpropanolamine—Methods to prevent sales violations—Department of health preparation of sign summarizing prohibitions.

RCW 69.43.160 Ephedrine, pseudoephedrine, phenylpropanolamine—Methods to prevent sales violations—Department of health preparation of sign summarizing prohibitions.(1) To prevent violations of RCW 69.43.110, every licensee and registrant under chapter 18.64 RCW, who sells at retail any products containing ephedrine, pseudoephedrine, or phenylpropanolamine, or their salts, isomers, or salts of isomers, shall do either or may do both of the following:(a) Program scanners, cash registers, or other electronic devices used to record sales in a manner that will alert persons handling transactions to potential violations of RCW 69.43.110(1) and/or prevent such violations; or(b) Place one or more signs on the premises to notify customers of the prohibitions of RCW 69.43.110. Any such sign may, but is not required to, conform to the language and format prepared by the department of health under subsection (2) of this section.(2) The department of health shall prepare language and format for a sign summarizing the prohibitions in RCW 69.43.110 and 69.43.120 and make the language and format available to licensees and registrants under chapter 18.64 RCW, for voluntary use in their places of business to inform customers and employees of the prohibitions. Nothing in this section requires the department of health to provide licensees or registrants with copies of signs, or any licensee or registrant to use the specific language or format prepared by the department under this subsection.[ 2001 c 96 § 14.]NOTES:Intent—Severability—2001 c 96: See notes following RCW 69.43.010.
WA Rev Code § 69.43.165 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.43 - Precursor Drugs.|69.43.165 - Ephedrine, pseudoephedrine, phenylpropanolamine—Electronic sales tracking system—Pharmacy quality assurance commission authority to adopt rules.

RCW 69.43.165 Ephedrine, pseudoephedrine, phenylpropanolamine—Electronic sales tracking system—Pharmacy quality assurance commission authority to adopt rules.(1) The pharmacy quality assurance commission shall implement a real-time electronic sales tracking system to monitor the nonprescription sale of products in this state containing any detectable quantity of ephedrine, pseudoephedrine, phenylpropanolamine, or their salts, isomers, or salts of isomers, provided that the system is available to the state without cost for accessing the system to the state or retailers. The commission is authorized to enter into a public-private partnership, through a memorandum of understanding or similar arrangement, to make the system available.(2) The records submitted to the tracking system are for the confidential use of the pharmacy, shopkeeper, or itinerant vendor who submitted them, except that:(a) The records must be produced in court when lawfully required;(b) The records must be open for inspection by the pharmacy quality assurance commission; and(c) The records must be available to any general or limited authority Washington peace officer to enforce the provisions of this chapter or to federal law enforcement officers in accordance with rules adopted by the pharmacy quality assurance commission regarding the privacy of the purchaser of products covered by chapter 182, Laws of 2010 and law enforcement access to the records submitted to the tracking system as provided in this section consistent with the federal combat meth act.(3) The electronic sales tracking system shall be capable of generating a stop sale alert, which shall be a notification that completion of the sale would result in the seller or purchaser violating the quantity limits in RCW 69.43.110 (1) and (2). The system shall contain an override function for use by a dispenser of ephedrine, pseudoephedrine, phenylpropanolamine, or their salts, isomers, or salts of isomers, who has a reasonable fear of imminent bodily harm. Each instance in which the override function is utilized shall be logged by the system.(4) The pharmacy quality assurance commission shall have the authority to adopt rules necessary to implement and enforce the provisions of this section. The pharmacy quality assurance commission shall adopt rules regarding the privacy of the purchaser of products covered by chapter 182, Laws of 2010, and any public or law enforcement access to the records submitted to the tracking system as provided in subsection (2)(c) of this section consistent with the federal combat meth act.(5) The pharmacy quality assurance commission may not raise licensing or registration fees to fund the rule making or implementation of this section.[ 2013 c 19 § 79; 2010 c 182 § 3.]
WA Rev Code § 69.43.168 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.43 - Precursor Drugs.|69.43.168 - Pharmacy, shopkeeper, or itinerant vendor—Electronic sales tracking system—Liability.

RCW 69.43.168 Pharmacy, shopkeeper, or itinerant vendor—Electronic sales tracking system—Liability.A pharmacy, shopkeeper, or itinerant vendor participating in the electronic sales tracking system under RCW 69.43.110(4):(1) Is not liable for civil damages resulting from any act or omission in carrying out the requirements of RCW 69.43.110(4), other than an act or omission constituting gross negligence or willful or wanton misconduct; and(2) Is not liable for civil damages resulting from a data breach that was proximately caused by a failure on the part of the electronic sales tracking system to take reasonable care through the use of industry standard levels of encryption to guard against unauthorized access to account information that is in the possession or control of the system.[ 2010 c 182 § 4.]
WA Rev Code § 69.43.180 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.43 - Precursor Drugs.|69.43.180 - Expansion of log requirements—Petition by law enforcement.

RCW 69.43.180 Expansion of log requirements—Petition by law enforcement.(1) The Washington association of sheriffs and police chiefs or the Washington state patrol may petition the pharmacy quality assurance commission to apply the log requirements in *RCW 69.43.170 to one or more products that contain ephedrine, pseudoephedrine, or phenylpropanolamine, or their salts, isomers, or salts of isomers, that is not the only active ingredient and that is in liquid, liquid capsule, or gel capsule form. The petition shall establish that:(a) Ephedrine, pseudoephedrine, or phenylpropanolamine can be effectively extracted from the product and converted into methamphetamine or another controlled dangerous substance; and(b) Law enforcement, the Washington state patrol, or the department of ecology are finding substantial evidence that the product is being used for the illegal manufacture of methamphetamine or another controlled dangerous substance.(2) The pharmacy quality assurance commission shall adopt rules when a petition establishes that requiring the application of the log requirements in *RCW 69.43.170 to the sale of the product at retail is warranted based upon the effectiveness and extent of use of the product for the illegal manufacture of methamphetamine or other controlled dangerous substances and the extent of the burden of any restrictions upon consumers. The pharmacy quality assurance commission may adopt emergency rules to apply the log requirements to the sale of a product when the petition establishes that the immediate restriction of the product is necessary in order to protect public health and safety.[ 2013 c 19 § 80; 2005 c 388 § 3.]NOTES:*Reviser's note: RCW 69.43.170 was repealed by 2010 c 182 § 6.Finding—Effective dates—Severability—2005 c 388: See notes following RCW 69.43.105.
WA Rev Code § 69.43.190 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.43 - Precursor Drugs.|69.43.190 - Products found at methamphetamine sites—Report.

RCW 69.43.190 Products found at methamphetamine sites—Report.Each county sheriff shall compile and maintain a record of commercial products containing ephedrine, pseudoephedrine, or phenylpropanolamine and packaging found at methamphetamine laboratory sites. The data shall be forwarded to the Washington association of sheriffs and police chiefs and shall be reported to the legislature by November 1, 2007, and annually thereafter.[ 2005 c 388 § 9.]NOTES:Finding—Effective dates—Severability—2005 c 388: See notes following RCW 69.43.105.
WA Rev Code § 69.45.020 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.020 - Registration of manufacturers—Additional information required by the department.

RCW 69.45.020 Registration of manufacturers—Additional information required by the department.A manufacturer that intends to distribute drug samples in this state shall register annually with the department, providing the name and address of the manufacturer, and shall:(1) Provide a twenty-four hour telephone number and the name of the individual(s) who shall respond to reasonable official inquiries from the department, as directed by the commission, based on reasonable cause, regarding required records, reports, or requests for information pursuant to a specific investigation of a possible violation. Each official request by the department and each response by a manufacturer shall be limited to the information specifically relevant to the particular official investigation. Requests for the address of sites in this state at which drug samples are stored by the manufacturer's representative and the names and addresses of the individuals who are responsible for the storage or distribution of the drug samples shall be responded to as soon as possible but not later than the close of business on the next business day following the request; or(2) If a twenty-four hour telephone number is not available, provide the addresses of sites in this state at which drug samples are stored by the manufacturer's representative, and the names and addresses of the individuals who are responsible for the storage or distribution of the drug samples. The manufacturer shall annually submit a complete updated list of the sites and individuals to the department.[ 2013 c 19 § 82; 1989 1st ex.s. c 9 § 445; 1987 c 411 § 2.]NOTES:Effective date—Severability—1989 1st ex.s. c 9: See RCW 43.70.910 and 43.70.920.
WA Rev Code § 69.45.030 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.030 - Records maintained by manufacturer—Report of loss or theft of drug samples—Reports of practitioners receiving controlled substance drug samples.

RCW 69.45.030 Records maintained by manufacturer—Report of loss or theft of drug samples—Reports of practitioners receiving controlled substance drug samples.(1) The following records shall be maintained by the manufacturer distributing drug samples in this state and shall be available for inspection by authorized representatives of the department based on reasonable cause and pursuant to an official investigation:(a) An inventory of drug samples held in this state for distribution, taken at least annually by a representative of the manufacturer other than the individual in direct control of the drug samples;(b) Records or documents to account for all drug samples distributed, destroyed, or returned to the manufacturer. The records shall include records for sample drugs signed for by practitioners, dates and methods of destruction, and any dates of returns; and(c) Copies of all reports of lost or stolen drug samples.(2) All required records shall be maintained for two years and shall include transaction dates.(3) Manufacturers shall report to the department the discovery of any loss or theft of drug samples as soon as possible but not later than the close of business on the next business day following the discovery.(4) Manufacturers shall report to the department as frequently as, and at the same time as, their other reports to the federal drug enforcement administration, or its lawful successor, the name, address and federal registration number for each practitioner who has received controlled substance drug samples and the name, strength and quantity of the controlled substance drug samples distributed.[ 1989 1st ex.s. c 9 § 446; 1987 c 411 § 3.]NOTES:Effective date—Severability—1989 1st ex.s. c 9: See RCW 43.70.910 and 43.70.920.
WA Rev Code § 69.45.040 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.040 - Storage and transportation of drug samples—Disposal of samples which have exceeded their expiration dates.

RCW 69.45.040 Storage and transportation of drug samples—Disposal of samples which have exceeded their expiration dates.(1) Drug samples shall be stored in compliance with the requirements of federal and state laws, rules, and regulations.(2) Drug samples shall be maintained in a locked area to which access is limited to persons authorized by the manufacturer.(3) Drug samples shall be stored and transported in such a manner as to be free of contamination, deterioration, and adulteration.(4) Drug samples shall be stored under conditions of temperature, light, moisture, and ventilation so as to meet the label instructions for each drug.(5) Drug samples which have exceeded the expiration date shall be physically separated from other drug samples until disposed of or returned to the manufacturer.[ 1987 c 411 § 4.]
WA Rev Code § 69.45.050 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.050 - Distribution of drug samples—Written request—No fee or charge permitted—Possession of legend drugs or controlled substances by manufacturers' representatives.

RCW 69.45.050 Distribution of drug samples—Written request—No fee or charge permitted—Possession of legend drugs or controlled substances by manufacturers' representatives.(1) Drug samples may be distributed by a manufacturer or a manufacturer's representative only to practitioners legally authorized to prescribe such drugs or, at the request of such practitioner, to pharmacies of hospitals or other health care entities. The recipient of the drug sample must execute a written receipt upon delivery that is returned to the manufacturer or the manufacturer's representative.(2) Drug samples may be distributed by a manufacturer or a manufacturer's representative only to a practitioner legally authorized to prescribe such drugs pursuant to a written request for such samples. The request shall contain:(a) The recipient's name, address, and professional designation;(b) The name, strength, and quantity of the drug samples delivered;(c) The name or identification of the manufacturer and of the individual distributing the drug sample; and(d) The dated signature of the practitioner requesting the drug sample.(3) No fee or charge may be imposed for sample drugs distributed in this state.(4) A manufacturer's representative shall not possess legend drugs or controlled substances other than those distributed by the manufacturer they represent. Nothing in this section prevents a manufacturer's representative from possessing a legally prescribed and dispensed legend drug or controlled substance.[ 1989 c 164 § 2; 1987 c 411 § 5.]NOTES:Legislative finding—1989 c 164: "The legislature finds that chapter 69.45 RCW is more restrictive than the federal prescription drug marketing act of 1987, and the legislature further finds that a change in chapter 69.45 RCW accepting the position of the federal law is beneficial to the citizens of this state." [ 1989 c 164 § 1.]
WA Rev Code § 69.45.060 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.060 - Disposal of surplus, outdated, or damaged drug samples.

RCW 69.45.060 Disposal of surplus, outdated, or damaged drug samples.Surplus, outdated, or damaged drug samples shall be disposed of as follows:(1) Returned to the manufacturer; or(2) Witnessed destruction by such means as to assure that the drug cannot be retrieved. However, controlled substances shall be returned to the manufacturer or disposed of in accordance with rules adopted by the commission: PROVIDED, That the commission shall adopt by rule the regulations of the federal drug enforcement administration or its lawful successor unless, stating reasonable grounds, it adopts rules consistent with such regulations.[ 2013 c 19 § 83; 1987 c 411 § 6.]
WA Rev Code § 69.45.070 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.070 - Registration fees—Penalty.

RCW 69.45.070 Registration fees—Penalty.The department may charge reasonable fees for registration. The registration fee shall not exceed the fee charged by the department for a pharmacy location license. If the registration fee is not paid on or before the date due, a renewal or new registration may be issued only upon payment of the registration renewal fee and a penalty fee equal to the registration renewal fee.[ 1991 c 229 § 8; 1989 1st ex.s. c 9 § 447; 1987 c 411 § 7.]NOTES:Effective date—Severability—1989 1st ex.s. c 9: See RCW 43.70.910 and 43.70.920.
WA Rev Code § 69.45.080 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.080 - Violations of chapter—Manufacturer's liability—Penalty—Seizure of drug samples.

RCW 69.45.080 Violations of chapter—Manufacturer's liability—Penalty—Seizure of drug samples.(1) The manufacturer is responsible for the actions and conduct of its representatives with regard to drug samples.(2) The commission may hold a public hearing to examine a possible violation and may require a designated representative of the manufacturer to attend.(3) If a manufacturer fails to comply with this chapter following notification by the commission, the commission may impose a civil penalty of up to five thousand dollars. The commission shall take no action to impose any civil penalty except pursuant to a hearing held in accordance with chapter 34.05 RCW.(4) Specific drug samples which are distributed in this state in violation of this chapter, following notification by the commission, shall be subject to seizure following the procedures set out in RCW 69.41.060.[ 2013 c 19 § 84; 1987 c 411 § 8.]
WA Rev Code § 69.45.090 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.45 - Drug Samples.|69.45.090 - Confidentiality.

RCW 69.45.090 Confidentiality.All records, reports, and information obtained by the commission from or on behalf of a manufacturer or manufacturer's representative under this chapter are confidential and exempt from public inspection and copying under chapter 42.56 RCW. This section does not apply to public disclosure of the identity of persons found by the commission to have violated state or federal law, rules, or regulations. This section is not intended to restrict the investigations and proceedings of the commission so long as the commission maintains the confidentiality required by this section.[ 2013 c 19 § 85; 2005 c 274 § 330; 1987 c 411 § 9.]